AbbVie Inc. diskutieren
AbbVie Inc.
WKN: A1J84E / Symbol: ABBV / Name: AbbVie / Aktie / Pharmazeutika / Large Cap /
177,40 €
-2,20 %
AbbVie (NYSE:ABBV) had its price target raised by analysts at Morgan Stanley from $269.00 to $270.00. They now have an "overweight" rating on the stock.
Ratings data for ABBV provided by MarketBeat
AbbVie (NYSE:ABBV) is now covered by analysts at Barclays PLC. They set an "overweight" rating and a $275.00 price target on the stock.
Ratings data for ABBV provided by MarketBeat
AbbVie (ABBV) had its "outperform" rating reaffirmed by BMO Capital Markets.
Ratings data for ABBV provided by MarketBeat
AbbVie (ABBV) had its "outperform" rating reaffirmed by William Blair.
Ratings data for ABBV provided by MarketBeat
AbbVie (ABBV) had its price target lowered by Cantor Fitzgerald from $250.00 to $240.00. They now have an "overweight" rating on the stock.
Ratings data for ABBV provided by MarketBeat
AbbVie (ABBV) had its price target raised by Guggenheim from $242.00 to $249.00. They now have a "buy" rating on the stock.
Ratings data for ABBV provided by MarketBeat
Neueste Beiträge
StockNews_com in American Eagle Outfitters diskutieren